Please login to the form below

Not currently logged in
Email:
Password:

apceth Biopharma appoints Dusan Kosijer as CFO

He joins the cell therapy company from Accovion GmbH

Dusan KosijerContract development and manufacturing organisation (CDMO) apceth Biopharma has promoted Dusan Kosijer to chief financial officer (CFO), a role that will see him further progress the firm’s business and executive strategy.

He joined Munich-based cell therapy-focused company in 2016 and was initially responsible for the company’s finance strategy and operations and the leadership of the accountant and purchasing team.

He said: “I am excited and honoured to be able to contribute to the company that operates successfully for almost 10 years in the fast-moving field of cell and gene therapy.

“We will continue to be relentless in our efforts to be the best and most reliable CDMO partner for the growing number of our renowned international clients.

“In parallel, apceth’s pipeline has recently entered a very thrilling phase, encouraging us to accelerate further the development of our first-in-class, first-in-man cell-based gene therapies.”

Kosijer has 14 years’ experience in corporate finance and pharmaceutical contract service businesses including Accovion GmbH - a European clinical research organisation now owned by Clinipace - where he was CFO.

Christine Guenther, CEO of apceth, said: “With Dusan’s longstanding background as a finance executive in the pharmaceutical contract services sector, Dusan will play a major role in further strengthening our successful track record as one of the leading CDMOs for complex cell and gene therapy products.

“Moreover, Dusan’s experience will strongly promote our dynamic innovative strategy behind apceth’s unique proprietary pipeline of genetically modified stem cell therapies.”

2nd June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics